The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sequential first-line treatment with gemcitabine plus nab-paclitaxel (GA) followed by FOLFIRINOX (FFX) versus FFX alone in patients with metastatic pancreatic cancer (PC): GABRINOX-2 randomized phase 2 trial.
 
Fabienne Portales
Honoraria - Sanofi; SERVIER (Inst)
Travel, Accommodations, Expenses - ipsen; Novartis
 
Eric Assenat
Consulting or Advisory Role - AAA HealthCare; AstraZeneca/MedImmune; Bayer; Ipsen; Roche
 
Emmanuelle Samalin
Consulting or Advisory Role - MSD Oncology (Inst); Pierre Fabre; SERVIER
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Merck Serono; Pierre Fabre; SERVIER
 
Thibault Mazard
Consulting or Advisory Role - AAA HealthCare; Amgen; Merck Serono; Pierre Fabre; Pierre Fabre; Sandoz; SERVIER
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Pierre Fabre
 
Antoine Adenis
Consulting or Advisory Role - Arcus Biosciences; Astellas Pharma; Bristol-Myers Squibb; Merck; Merck Serono
Speakers' Bureau - Bristol-Myers Squibb; MSD Oncology
Research Funding - Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; SERVIER
 
Blandine Suchet Gallet
No Relationships to Disclose
 
Catherine Fiess
No Relationships to Disclose
 
Aurore Moussion
No Relationships to Disclose
 
Stephanie Delaine
No Relationships to Disclose
 
Florin Grigorescu
No Relationships to Disclose
 
Sophie Gourgou
Consulting or Advisory Role - Celgene; Roche
 
Marc Ychou
Honoraria - Bayer